反応式
[N:1]1[CH:6]=[CH:5][CH:4]=[CH:3][C:2]=1[NH:7][C:8]([C:10]1[N:11]([CH3:22])[S:12](=[O:21])(=[O:20])[C:13]2[CH:19]=[CH:18][S:17][C:14]=2[C:15]=1[OH:16])=[O:9].C(N(CC)CC)C.[C:30](Cl)([Cl:32])=[O:31]>C1(C)C=CC=CC=1>[ClH:32].[CH3:22][N:11]1[C:10]2[C:8](=[O:9])[N:7]([C:2]3[CH:3]=[CH:4][CH:5]=[CH:6][N:1]=3)[C:30](=[O:31])[O:16][C:15]=2[C:14]2[S:17][CH:18]=[CH:19][C:13]=2[S:12]1(=[O:21])=[O:20]参加物
5
実験手順
To a solution of 3.37 g. (10 mmole) N-(2-pyridyl)-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide 1,1-dioxide (tenoxicam) in 150 ml. toluene under nitrogen is added 1.01 g. (10 mmole) triethylamine and the mixture is cooled to 0° C. The cold solution is then added dropwise to a solution of 1.0 g. (10 mmole) phosgene in 50 ml. toluene at -70° C. over 45 minutes and stirring is continued at -70° to -60° C. for an additional 30 minutes. The reaction mixture is allowed to warm to room temperature and stirred for an hour. The solvent is evaporated in vacuo, the residue triturated with acetone and filtered to obtain the desired product which is purified by recrystallization, e.g., from acetine, ethanol or chloroform.
後処理
- additionThe cold solution is then added dropwise to a solution of 1.0 g
- stirringstirred for an hour
- customThe solvent is evaporated in vacuo
- customthe residue triturated with acetone
- filtrationfiltered
出典と根拠
- ORDレコード
- ord-b971470fe1ed433b816949f64be0e5c7
- 出典データセット
- uspto-grants-1987_04
- 特許番号
- US04656265
関連ノート
読み込み中…